🔬 Science
April 08, 2026 at 06:30 PM
Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis
Source:
Good News Network
Johns Hopkins researchers are developing a novel nose-delivered DNA vaccine for tuberculosis, aiming to combat the world's leading infectious killer by targeting drug-tolerant bacteria.
tuberculosis vaccine
medical breakthrough
Johns Hopkins
DNA vaccine